Vita Life Sciences Limited Announces Consolidated Earnings Results for the Half Year Ended June 30, 2016; Provides Earnings Guidance for the Full Year of 2016
August 22, 2016 at 12:05 pm IST
Share
Vita Life Sciences Limited announced consolidated earnings results for the half year ended June 30, 2016. For the half year, the company reported revenue was AUD 18.1 million against AUD 18.2 million a year ago. EBITDA was AUD 3.1 million against AUD 2.4 million a year ago. EBIT was AUD 3.0 million against AUD 2.4 million a year ago. Profit before tax was AUD 2.9 million against AUD 2.3 million a year ago. Profit after tax was AUD 1.8 million against AUD 1.6 million a year ago. Diluted EPS was 3.3 cents against 2.8 cents a year ago. Gross operating cash flow was AUD 1.0 million against AUD 3.4 million a year ago. Operating cash flows was AUD 0.9 million against AUD 3.0 million a year ago
Based on trading to June 2016 and no material changes within the company's regions of operation directors provide the following guidance for the 2016 full year. The full year revenue is expected to be AUD 39 million and full year EBIT is expected of AUD 6.00 million to AUD 6.75 million.
Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The Company is involved in formulating, packaging, sales and distributing vitamins and supplements. Its core business is the development and distribution of over-the-counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. Its brand portfolio includes Herbs of Gold, VitaHealth, VitaScience and VitaLife. Herbs of Gold brand produces premium herbal, mineral, vitamin and superfood products. VitaHealth brand offers a comprehensive range of nutritional products that cater to every health need, from inner wellness to outer radiance. VitaScience is a vivacious nutritional supplement brand that offers practitioner strength quality formulations. Its subsidiaries include Vita Healthcare Asia Pacific Sdn Bhd, Herbs of Gold Sdn Bhd and others.
Vita Life Sciences Limited Announces Consolidated Earnings Results for the Half Year Ended June 30, 2016; Provides Earnings Guidance for the Full Year of 2016